Trial Profile
A Randomized Phase III Study: Paclitaxel Plus Radiation Therapy With or Without Erlotinib in Treating Patients With Esophageal Squamous Carcinoma
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary) ; Paclitaxel (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 18 Jan 2013 New trial record